BlackRock
MAIA icon

BlackRock’s MAIA Biotechnology MAIA Stock Holding History

BlackRock’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$580K Buy
403,011
+275,033
+215% +$365K ﹤0.01% 4531
2026
Q1 		$179K Buy
127,978
+20,733
+19% +$38.2K ﹤0.01% 4803
2025
Q4 		$164K Buy
107,245
+2,388
+2% +$3.12K ﹤0.01% 4781
2025
Q3 		$161K Buy
104,857
+1,592
+2% +$2.6K ﹤0.01% 4728
2025
Q2 		$186K Buy
103,265
+19,182
+23% +$34.3K ﹤0.01% 4692
2025
Q1 		$129K Sell
84,083
-702
-0.8% -$1.3K ﹤0.01% 4705
2024
Q4 		$168K Buy
84,785
+5,058
+6% +$12.1K ﹤0.01% 4656
2024
Q3 		$224K Buy
79,727
+1,206
+2% +$3.76K ﹤0.01% 4507
2024
Q2 		$269K Buy
78,521
+61,529
+362% +$194K ﹤0.01% 4488
2024
Q1 		$37.4K Sell
16,992
-217
-1% -$326 ﹤0.01% 4933
2023
Q4 		$20.1K Buy
17,209
+3,237
+23% +$5.22K ﹤0.01% 5084
2023
Q3 		$30.7K Buy
13,972
+5,955
+74% +$11.8K ﹤0.01% 5085
2023
Q2 		$17.6K Buy
8,017
+4,011
+100% +$10.7K ﹤0.01% 5212
2023
Q1 		$13.9K Buy
4,006
+132
+3% +$542 ﹤0.01% 5292
2022
Q4 		$13.6K Buy
3,874
+302
+8% +$1.04K ﹤0.01% 5423
2022
Q3 		$12K Buy
+3,572
New +$15.1K ﹤0.01% 5574

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock's MAIA Position: Q2 2026 in Review

BlackRock increased its MAIA Biotechnology (MAIA) stake by 215% in Q2 2026, buying an estimated $365K and bringing the position to 403,011 shares worth $580K. The position accounts for ﹤0.01% of the portfolio, ranked #4531.

BlackRock first reported a position in MAIA in Q3 2022 and has held it in 16 quarters since. 36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • BlackRock held 403,011 shares of MAIA Biotechnology worth $580K as of Q2 2026.
  • BlackRock bought 275,033 MAIA Biotechnology shares in Q2 2026, an estimated $365K.
  • MAIA Biotechnology made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4531 holding.
  • BlackRock first reported a position in MAIA Biotechnology in Q3 2022 and has held it in 16 quarters since.
  • 36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.